Neurogene, Inc. (NGNE)
Neurogene Market Cap: 294.15M for Jan. 22, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| CorMedix, Inc. | 586.19M |
| Verastem, Inc. | 503.89M |
| Anavex Life Sciences Corp. | 473.54M |
| Coherus Oncology, Inc. | 192.18M |
| Ocugen, Inc. | 541.02M |
Market Cap Related Metrics
| Price to Book Value | 1.108 |
| Price | 18.99 |
| Earnings Yield | -23.32% |